| CAR-NK cells: A promising cellular immunotherapy for cancer G Xie, H Dong, Y Liang, JD Ham, R Rizwan, J Chen EBioMedicine 59, 2020 | 520 | 2020 |
| mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting JJ Lohmueller, JD Ham, M Kvorjak, OJ Finn Oncoimmunology 7 (1), e1368604, 2018 | 116 | 2018 |
| Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia H Dong, JD Ham, G Hu, G Xie, J Vergara, Y Liang, A Ali, M Tarannum, ... Proceedings of the National Academy of Sciences 119 (25), e2122379119, 2022 | 54 | 2022 |
| Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential JJ Lohmueller, S Sato, L Popova, IM Chu, MA Tucker, R Barberena, ... Scientific reports 6 (1), 31740, 2016 | 35 | 2016 |
| Engineered memory-like NK cars targeting a neoepitope derived from intracellular NPM1c exhibit potent activity and specificity against acute myeloid leukemia H Dong, G Xie, Y Liang, JD Ham, J Vergara, J Chen, J Ritz, R Romee Blood 136, 3-4, 2020 | 13 | 2020 |
| Ovarian cancer ascites inhibits transcriptional activation of nk cells partly through Ca125 CC Fraser, B Jia, G Hu, LI Al Johani, R Fritz-Klaus, JD Ham, RN Fichorova, ... The Journal of Immunology 208 (9), 2227-2238, 2022 | 8 | 2022 |
| Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia Y Liu-Lupo, JD Ham, SKA Jeewajee, L Nguyen, T Delorey, A Ramos, ... Blood Cancer Journal 13 (1), 92, 2023 | | 2023 |
